chr9-77425622-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_004297.4(GNA14):c.817G>C(p.Asp273His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000746 in 1,607,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004297.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GNA14 | NM_004297.4 | c.817G>C | p.Asp273His | missense_variant | 6/7 | ENST00000341700.7 | |
GNA14 | XM_047424110.1 | c.463G>C | p.Asp155His | missense_variant | 5/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GNA14 | ENST00000341700.7 | c.817G>C | p.Asp273His | missense_variant | 6/7 | 1 | NM_004297.4 | P1 | |
GNA14 | ENST00000464095.1 | n.592G>C | non_coding_transcript_exon_variant | 3/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152172Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000598 AC: 15AN: 250794Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135528
GnomAD4 exome AF: 0.00000687 AC: 10AN: 1455594Hom.: 0 Cov.: 27 AF XY: 0.00000552 AC XY: 4AN XY: 724584
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152290Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 19, 2024 | The c.817G>C (p.D273H) alteration is located in exon 6 (coding exon 6) of the GNA14 gene. This alteration results from a G to C substitution at nucleotide position 817, causing the aspartic acid (D) at amino acid position 273 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Cerebrofacial arteriovenous metameric syndrome Uncertain:1
Uncertain significance, no assertion criteria provided | research | KK Women’s and Children’s Hospital | Apr 04, 2023 | Inherited from asymptomatic mother - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at